Childrens Medical Center Corporation;Children's Medical Center Corporation
发明人:
KAGAN, Jonathan, C.
申请号：
EP16737709
公开号：
EP3244923A4
申请日:
2016.01.12
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention provides methods and compositions for specific activation of inflammatory responses in dendritic cells (DCs). 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (PAPC) and its oxidized variant (oxPAPC) were identified to promote DC-mediated immunity, and are provided as adjuvants in immunostimulatory compositions, including vaccines.
